Managing Director Nicholas Meserve purchased 2,500 shares at $11.43, marking the largest insider purchase in the company's history. This significant bet comes as the stock trades near its 52-week low, potentially signaling confidence in the high dividend yield and undervalued status.
Price context
The shares have dropped 5.18% over the past five days and 8.29% over the last month, bringing the current price to $11.17, which is just 0.04% above the 52-week low of $11.165.
Catalysts to watch
- •The largest-ever insider purchase by Nicholas Meserve on June 23.
- •Analyst sentiment remains constructive with Citizens JMP upgrading the stock to Outperform with a $15 price target on November 18.
Risks
The fund faces challenges with private loan investments and non-accrual assets, as highlighted in the Q2 2025 earnings call summary on August 15.
AI-generated context from public data. Not investment advice. Verify before trading.